This content is PDF only. Please click on the PDF icon to access.
Sixteen short papers and three groups of discussions apparently representing an unidentified symposium concerned with Zoladex, a luteinizing-hormone-releasing analog (ICI Americas, Inc., Wilmington, Delaware). They focus on management of premenopausal advanced breast cancer, premenopausal early-stage breast cancer, and postmenopausal stage I breast cancer. This is volume 1 in the series, Current Controversies in the Treatment of Breast Cancer.
The Role of Antihormones. Ann Intern Med. ;115:76. doi: 10.7326/0003-4819-115-1-76_4
Download citation file:
Published: Ann Intern Med. 1991;115(1):76.
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use